XML 45 R34.htm IDEA: XBRL DOCUMENT
v3.20.2

Shareholders' Equity and Debt (Shareholders' Equity) (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 9 Months Ended |  |
--- | --- | --- | --- | --- | ---
Apr. 30, 2019 | Nov. 30, 2017 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Sep. 30, 2019 | Jun. 30, 2019 | Mar. 31, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | Jan. 31, 2016 | May 13, 2010
Shareholders' Equity (Textual) [Abstract] |  |  |  |  |  |  |  |  |  |  |  |
Repurchase outstanding common shares |  |  |  |  |  |  |  |  |  |  | $ 10,000,000 | $ 10,000,000
Repurchase of shares (in shares) |  |  |  |  |  |  |  |  | 10,080 |  |  |
Repurchase of shares, value |  |  | $ (332,504) | $ (769,648) | $ (441,624) | $ (1,361,689) | $ (531,746) | $ (703,790) |  |  |  |
Shelf Registration, sale of corporate securities (up to) |  | $ 100,000,000 |  |  |  |  |  |  |  |  |  |
Contribution of cash | $ 300,000 |  |  |  |  |  |  |  |  |  |  |
Conversion of intercompany loans payable | 700,000 |  |  |  |  |  |  |  |  |  |  |
WinHealth |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) [Abstract] |  |  |  |  |  |  |  |  |  |  |  |
Investment through purchase of shares of CET Stock | 1,000,000 |  |  |  |  |  |  |  |  |  |  |
Gloria Pharmaceuticals |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) [Abstract] |  |  |  |  |  |  |  |  |  |  |  |
Cash payments for return of shares | $ 800,000 |  |  |  |  |  |  |  |  |  |  |
Restricted Stock |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) [Abstract] |  |  |  |  |  |  |  |  |  |  |  |
Restricted stock granted in period, shares |  |  |  |  |  |  |  |  | 230,491 | 225,869 |  |
Director | Restricted Stock |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) [Abstract] |  |  |  |  |  |  |  |  |  |  |  |
Restricted stock awards, vesting period |  |  |  |  |  |  |  |  | 1 year |  |  |
Common stock |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) [Abstract] |  |  |  |  |  |  |  |  |  |  |  |
Repurchase of shares (in shares) |  |  | 101,354 | 141,463 | 164,866 | 246,242 | 84,447 | 121,466 | 407,683 | 452,155 |  |
Repurchase of shares, value |  |  | $ (332,504) | $ (769,648) | $ (441,624) | $ (1,361,689) | $ (531,746) | $ (703,790) | $ (1,500,000) | $ (2,600,000) |  |

X
- Definition Shareholders Equity. + References No definition available. + Details
Name: | cpix_ShareholdersEquityTextualAbstract
Namespace Prefix: | cpix_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities
Namespace Prefix: | cpix_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Subsidiary Investment, Cash Contribution + References No definition available. + Details
Name: | cpix_SubsidiaryInvestmentCashContribution
Namespace Prefix: | cpix_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Subsidiary Investment, Conversion Of Intercompany Loans Payable + References No definition available. + Details
Name: | cpix_SubsidiaryInvestmentConversionOfIntercompanyLoansPayable
Namespace Prefix: | cpix_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Subsidiary Investment, Payments For Return Of Capital + References No definition available. + Details
Name: | cpix_SubsidiaryInvestmentPaymentsForReturnOfCapital
Namespace Prefix: | cpix_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Subsidiary Investment, Purchase Of Shares + References No definition available. + Details
Name: | cpix_SubsidiaryInvestmentPurchaseOfShares
Namespace Prefix: | cpix_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of stock repurchase plan authorized. + References No definition available. + Details
Name: | us-gaap_StockRepurchaseProgramAuthorizedAmount1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_StockRepurchasedDuringPeriodShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_StockRepurchasedDuringPeriodValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | srt_CounterpartyNameAxis=cpix_HongKongWinHealthPharmaGroupCoLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=cpix_GloriaPharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_DirectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |